We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.68%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$88.8B
AUM Growth
+$10B
(+13%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
3,325
New
753
Increased
947
Reduced
893
Closed
691
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRCL
Circle Internet Group
CRCL
|
+$1.39B |
| 2 |
NVIDIA
NVDA
|
+$910M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
T-Mobile US
TMUS
|
+$432M |
| 5 |
Eli Lilly
LLY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Tesla
TSLA
|
+$880M |
| 3 |
Danaher
DHR
|
+$535M |
| 4 |
Intuit
INTU
|
+$467M |
| 5 |
Visa
V
|
+$437M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Consumer Discretionary | 13.54% |
| 3 | Healthcare | 10.42% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Viemed Healthcare
VMD
$355M
| $147K | ﹤0.01% |
+21,279
| New | +$144K |
|
|
ARDT
2477
Ardent Health
ARDT
$1.59B
| $147K | ﹤0.01% |
+10,749
| New | +$145K |
|
2478
iShares Biotechnology ETF
IBB
$9.82B
| $145K | ﹤0.01% |
+1,147
| New | +$141K |
|
2479
Roadzen
RDZN
$108M
| $144K | ﹤0.01% |
+147,318
| New | +$148K |
|
2480
iShares MSCI Brazil Small-Cap ETF
EWZS
$218M
| $138K | ﹤0.01% |
+10,373
| New | +$125K |
|
2481
Actinium Pharmaceuticals
ATNM
$24.2M
| $137K | ﹤0.01% |
+98,123
| New | +$147K |
|
2482
Corbus Pharmaceuticals
CRBP
$177M
| $137K | ﹤0.01% |
+19,871
| New | +$144K |
|
2483
Wolfspeed
WOLF
$1.52B
| $134K | ﹤0.01% |
334,346
-481,461
| -59% | -$1.1M |
|
2484
Orchestra BioMed
OBIO
$267M
| $133K | ﹤0.01% |
+49,465
| New | +$144K |
|
2485
Imperial Petroleum
IMPP
$210M
| $132K | ﹤0.01% |
42,976
-59,568
| -58% | -$164K |
|
2486
Peloton Interactive
PTON
$2.42B
| $131K | ﹤0.01% |
18,935
-146,480
| -89% | -$951K |
|
2487
Forrester Research
FORR
$221M
| $131K | ﹤0.01% |
+13,251
| New | +$132K |
|
|
ZYXI
2488
DELISTED
Zynex
ZYXI
| $131K | ﹤0.01% |
+50,605
| New | +$114K |
|
|
FLNA
2489
Filana Therapeutics
FLNA
$48.2M
| $130K | ﹤0.01% |
+71,714
| New | +$128K |
|
|
BZUN
2490
Baozun
BZUN
$170M
| $129K | ﹤0.01% |
51,568
-7,872
| -13% | -$21.8K |
|
2491
Citizens
CIA
$194M
| $129K | ﹤0.01% |
+36,835
| New | +$144K |
|
2492
Purple Innovation
PRPL
$39.6M
| $128K | ﹤0.01% |
+7,025
| New | +$129K |
|
|
FSP
2493
Franklin Street Properties
FSP
$45.3M
| $128K | ﹤0.01% |
77,792
-346,970
| -82% | -$578K |
|
2494
CALL
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $127K | ﹤0.01% |
1,000
-96,600
| -99% | -$10.7M |
|
2495
Real Brokerage
REAX
$466M
| $127K | ﹤0.01% |
+28,062
| New | +$121K |
|
2496
Montauk Renewables
MNTK
$243M
| $126K | ﹤0.01% |
56,901
+34,914
| +159% | +$73.9K |
|
2497
FuelCell Energy
FCEL
$1.59B
| $122K | ﹤0.01% |
+21,700
| New | +$105K |
|
2498
KORU Medical Systems
KRMD
$157M
| $122K | ﹤0.01% |
34,004
-61,180
| -64% | -$174K |
|
2499
ICL Group
ICL
$6.89B
| $119K | ﹤0.01% |
17,349
-20,475
| -54% | -$134K |
|
2500
Blink Charging
BLNK
$86M
| $119K | ﹤0.01% |
+126,711
| New | +$101K |
|
Similar funds
Marshall Wace's Q2 2025 Portfolio in Review
As of Q2 2025, Marshall Wace held 3,325 positions worth $88.8B, up 13% from $78.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marshall Wace's Q2 2025 filing shows 753 new, 947 increased, 893 reduced and 691 closed positions. Its largest new stake was Circle Internet Group: 8,534,470 shares worth $1.55B. The largest sale was iShares Core S&P 500 ETF, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q2 2025 buy was Circle Internet Group: 8,534,470 shares worth $1.55B.
- Marshall Wace added most to NVIDIA in Q2 2025, an estimated $910M increase.
- Marshall Wace's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.3B.
- Marshall Wace fully exited Cboe Global Markets in Q2 2025, selling an estimated $191M.
- Marshall Wace's ten largest holdings make up 31% of its $88.8B portfolio in Q2 2025.
- Marshall Wace opened 753 new positions and closed 691 in Q2 2025.
- Marshall Wace's portfolio value rose 13% quarter-over-quarter to $88.8B.
Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.